← Leaderboards
Wilbur A Lam
Emory University
$39,688,140
Attributed
$45,961,856
Total exposure
24
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $60.8M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$138,937,129 · 25
By mechanism
U54$108,402,859 · 7
N02$11,071,332 · 1
R01$9,627,963 · 4
R35$4,995,037 · 1
R44$1,418,466 · 1
R21$1,396,830 · 3
Top collaborators
- Gregory S Martin14 shared
- Oliver Brand8 shared
- Christopher Bradley Doering5 shared
- Thomas Harrison Barker4 shared
- H Trent Spencer4 shared
- Eric M Vogel4 shared
- David Kevin Wood4 shared
- Gari David Clifford3 shared
Most similar at Emory University
Same institution · by research overlap
- Cheryl Maier$1,473,950
- David Richard Myers$6,395,874
- Gregory S Martin$5,670,342
- Nina Guzzetta$225,245
- Joshua Strauss$2,105,724
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyEngineeringMicrofluidicsBiomedical EngineeringDiagnosticBaseBloodProgramsDevicesHematologyTranslationsCollaborationsMicrosystemsDesignDoctor Of PhilosophyValidationInnovationTechnology DevelopmentCellsLaboratoriesHematological DiseaseClinical ResearchNanotechnologyAdoption
Grant awards (85)
RADx Innovation Funnel for Health Technologies - Validation Center$4,905,722
N02 · FY2025 · EB · contact PI
RADx Innovation Funnel for HIV diagnostics â Validation Center$4,665,610
N02 · FY2025 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,561,849
U54 · FY2025 · EB · contact PI
Technology Core$958,939
U54 · FY2025 · EB · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$775,204
R35 · FY2025 · HL · contact PI
Administrative Core$191,905
U54 · FY2025 · EB · contact PI
Advancement of Diagnostics by Joining User-centered and Scalable Technologies - Training Program (ADJUST TP)$108,384
T32 · FY2025 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,561,849
U54 · FY2024 · EB · contact PI
RADx Innovation Funnel for HIV diagnostics â Validation Center$1,500,000
N02 · FY2024 · EB · contact PI
Technology Core$958,939
U54 · FY2024 · EB · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$742,114
R35 · FY2024 · HL · contact PI
Administrative Core$191,905
U54 · FY2024 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,618,350
U54 · FY2023 · EB · contact PI
Technology Core$973,068
U54 · FY2023 · EB · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$784,500
R35 · FY2023 · HL · contact PI
Administrative Core$206,024
U54 · FY2023 · EB · contact PI
ACME POCT EMERGENCY COVID-19 VARIANT TESTING & INDEPENDENT TEST ASSESSMENT EVALUATION SUPPLEMENT$15,864,683
U54 · FY2022 · EB · contact PI
Emergency COVID-19 Variant Supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$15,481,896
U54 · FY2022 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,372,712
U54 · FY2022 · EB · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$769,601
R35 · FY2022 · HL · contact PI
Technology Development Core$768,868
U54 · FY2022 · EB · contact PI
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.$698,934
R44 · FY2022 · HL
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$648,527
U54 · FY2022 · EB · contact PI
Administrative Core$195,881
U54 · FY2022 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,373,615
U54 · FY2021 · EB · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$764,994
R35 · FY2021 · HL · contact PI
Technology Development Core$752,756
U54 · FY2021 · EB · contact PI
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies$719,801
R01 · FY2021 · HL · contact PI
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.$719,532
R44 · FY2021 · HL
A microfluidics-based paradigm for clinical lentivector gene transfer$500,223
R01 · FY2021 · HL · contact PI
Administrative Core$222,257
U54 · FY2021 · EB · contact PI
Emergency COVID-19 supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technoloites (ACME POCT)$31,080,737
U54 · FY2020 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$11,194,205
U54 · FY2020 · EB · contact PI
Administrative Core$7,085,000
U54 · FY2020 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$7,085,000
U54 · FY2020 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,374,470
U54 · FY2020 · EB · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$757,302
R35 · FY2020 · HL · contact PI
Technology Development Core$753,611
U54 · FY2020 · EB · contact PI
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies$736,952
R01 · FY2020 · HL · contact PI
A microfluidics-based paradigm for clinical lentivector gene transfer$500,223
R01 · FY2020 · HL · contact PI
Administrative Core$222,257
U54 · FY2020 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,376,145
U54 · FY2019 · EB · contact PI
Technology Development Core$755,286
U54 · FY2019 · EB · contact PI
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies$749,772
R01 · FY2019 · HL · contact PI
Platelet-like particles for augmenting hemostasis$656,680
R01 · FY2019 · HL
A microfluidics-based paradigm for clinical lentivector gene transfer$492,987
R01 · FY2019 · HL · contact PI
Engineering biophysical microtechnologies for hematologic applications in health and disease$401,322
R35 · FY2019 · HL · contact PI
Leveraging microfluidic technologies and cell-scale simulations to investigate sickle cell vasculopathy$231,750
R21 · FY2019 · MD · contact PI
A Microscale Platform for Augmentation of Cell Transduction (MPACT) to Enhance Ex Vivo Gene Transfer$224,999
R43 · FY2019 · HL
HLS- SBIR Phase I: Targeted platelet-capsule hybrids for on demand treatment in hemophilia$223,898
R43 · FY2019 · HL
Administrative Core$222,257
U54 · FY2019 · EB · contact PI
Non-invasive quantitative hemoglobin self-monitoring using only smartphone images for chronic anemia patients$175,839
R21 · FY2019 · EB · contact PI
On-demand smartphone app for non-invasive anemia detection using only patient-sourced photos in low resource settings.$150,000
R43 · FY2019 · HL
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,381,235
U54 · FY2018 · EB · contact PI
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies$791,236
R01 · FY2018 · HL · contact PI
Technology Development Core$732,376
U54 · FY2018 · HL · contact PI
Platelet-like particles for augmenting hemostasis$659,445
R01 · FY2018 · HL
A microfluidics-based paradigm for clinical lentivector gene transfer$492,987
R01 · FY2018 · HL · contact PI
Endothelialized microfluidics for sickle cell disease research & drug discovery$390,164
R01 · FY2018 · HL · contact PI
Administrative Core$236,257
U54 · FY2018 · HL · contact PI
Non-invasive quantitative hemoglobin self-monitoring using only smartphone images for chronic anemia patients$229,637
R21 · FY2018 · EB · contact PI
Leveraging microfluidic technologies and cell-scale simulations to investigate sickle cell vasculopathy$207,140
R21 · FY2018 · MD · contact PI
HLS- SBIR Phase I: Development of a robust, color-based, disposable, standalone anemia test for low-resource settings$150,000
R43 · FY2018 · HL
Non-invasive quantitative hemoglobin self-monitoring using only smartphone images for chronic anemia patients$147,861
R21 · FY2018 · EB · contact PI
Summer Research Experience Programs$91,775
R25 · FY2018 · HD
Administrative Supplement to Promote Diversity for Development of a robust, color-based, disposable, standalone anemia test for low-resource settings (Parent grant: 1 R43 HL139250-01A1)$67,167
R43 · FY2018 · HL
Concept to Clinical: Commercializing Innovation (C3i) Program for AnemoCheck-D: a robust, color-based, disposable, standalone anemia test for low-resource settings$30,000
R43 · FY2018 · HL
Platelet-like particles for augmenting hemostasis$662,132
R01 · FY2017 · HL
Endothelialized microfluidics for sickle cell disease research & drug discovery$390,164
R01 · FY2017 · HL · contact PI
Summer Research Experience Programs$91,775
R25 · FY2017 · HD
Platelet-like particles for augmenting hemostasis$705,500
R01 · FY2016 · HL
Endothelialized microfluidics for sickle cell disease research & drug discovery$390,164
R01 · FY2016 · HL · contact PI
Microfluidic Monitoring of Single Cell Elasticity, Viscoelasticity, and Plasticity$176,508
R21 · FY2016 · EB
Endothelialized microfluidics for sickle cell disease research & drug discovery$388,211
R01 · FY2015 · HL · contact PI
Microfluidic Monitoring of Single Cell Elasticity, Viscoelasticity, and Plasticity$228,095
R21 · FY2015 · EB
Endothelialized microfluidics for sickle cell disease research & drug discovery$401,322
R01 · FY2014 · HL · contact PI
Nanomechanical effects of aldosterone on vaso-occulation in sickle cell disease$126,144
K08 · FY2013 · HL · contact PI
Nanomechanical effects of aldosterone on vaso-occulation in sickle cell disease$126,144
K08 · FY2012 · HL · contact PI
Nanomechanical effects of aldosterone on vaso-occulation in sickle cell disease$126,144
K08 · FY2011 · HL · contact PI
Nanomechanical effects of aldosterone on vaso-occulation in sickle cell disease$131,976
K08 · FY2010 · HL · contact PI
Nanomechanical effects of aldosterone on vaso-occulation in sickle cell disease$131,976
K08 · FY2009 · HL · contact PI
Nanomechanics of Acute Leukemia$63,122
F32 · FY2007 · HL · contact PI
Nanomechanics of Acute Leukemia$63,122
F32 · FY2006 · HL · contact PI
Nanomechanics of Acute Leukemia$60,438
F32 · FY2005 · HL
Nanomechanics of Acute Leukemia$57,578
F32 · FY2004 · HL